News

Gladstone in the News July 26, 2022

Why Federal Government Is Putting Second COVID Boosters ‟On Hold” for People under 50

ABC7 News—The federal government plans to roll out a new vaccine against the BA.5 Omicron variant now predominant in the US early this fall. Senior Investigator Warner Greene, MD, PhD, says that you might want to hold off for your next booster shot until you can get this new vaccine, which will offer better protection against currently circulating variants.

Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab

Gladstone in the News July 25, 2022

Researchers Find SARS-CoV-2 Antibodies Less Effective against Omicron

The Daily Californian—Senior Investigator Melanie Ott, MD, PhD, and collaborator Abdullah Syed, PhD, a postdoctoral fellow in the laboratory of Senior Investigator Jennifer Doudna, explain how they discovered that antibodies against early versions of the SARS-CoV-2 virus do not protect well against the now widespread and highly contagious Omicron variant, and recommend masking to avoid new infections.

Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab

Article July 20, 2022

What Makes Omicron More Infectious Than Other COVID-19 Variants

Researchers used virus-like particles to identify which mutations of the Omicron SARS-CoV-2 virus make it more effective at infecting cells and escaping antibodies

News Release Research (Publication) COVID-19 Infectious Disease Doudna Lab Ott Lab

Article July 19, 2022

BETting On COVID-19: Study Probes Role of BET Proteins in Coronavirus Infection

Gladstone researchers find new evidence against using BET inhibitors to treat COVID-19

News Release Research (Publication) COVID-19 Infectious Disease Ott Lab

Gladstone in the News July 19, 2022

Finding HIV’s “Sweet Spot”

NIH Director’s Blog—Recent work from the team of Gladstone Associate Investigator Nadia Roan, PhD, and their colleagues at The Wistar Institute is featured in this week's NIH Director's Blog. The work uncovers intriguing evidence for the role of sugars at the surface of immune cells in HIV infection.

Gladstone Experts HIV/AIDS Infectious Disease Roan Lab

Article July 15, 2022

Gladstone Slack Emojis Now Available

Celebrating the modern world of communication with new Slack emojis

Communications

Article July 11, 2022

Scientists Map Networks of Disease-Associated Immune Genes

The new immune networks have implications for developing immunotherapies and understanding autoimmune diseases

News Release Research (Publication) Autoimmune Diseases Genomic Immunology Marson Lab

Video July 7, 2022

Out in Science: Queer Futurism in STEM

Hear LGBTQ+ STEM professionals discuss issues affecting the queer community in the sciences

LGBTQ Diversity

Article July 6, 2022

Pathway Deep in the Brain Makes It Resilient after Injury

Study suggests that targeting a protein in the thalamus could block the long-term damage that follows brain injuries

News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz Lab

Article July 5, 2022

Finding HIV’s Sweet Spot

Gladstone scientists uncover novel aspects of HIV infection by monitoring sugars at the surface of individual immune cells

News Release Research (Publication) HIV/AIDS Infectious Disease Roan Lab

Gladstone in the News June 30, 2022

Omicron Subvariants BA.4, BA.5 Are Spreading ‟Like Wildfire”, Becoming Dominant Strains in US

ABC7 News—As Omicron BA.4 and BA.5 variants overtake previous coronavirus variants across the United States, Gladstone Associate Investigator Nadia Roan, PhD, explains that their success may owe both to their ability to escape our immune system and to their accelerated replication rate. She suggests that more effort should be made to block infection at the level of the airways, the virus's entry point into our body.

Gladstone Experts COVID-19 Roan Lab

Article June 27, 2022

5 Questions with Gabriela M. Zabala Alemán

A science educator describes how their mentor impacted their career

Profile Diversity

Article June 24, 2022

The 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte

Izpisua Belmonte is recognized for his innovative work in programming cellular rejuvenation

Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs

Article June 23, 2022

Scientists Prevent “Exhaustion” in Cancer-Fighting T Cells

The new study paves the way toward more effective cancer immunotherapies

News Release Cancer Genomic Immunology Marson Lab

Gladstone in the News June 22, 2022

Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research

Cancer Research Institute—The Cancer Research Institute recently announced its newest cohort of Scientists Taking Risks (STAR) funding for high risk/high reward research in tumor biology. Of the six recipients, three are core members of the Gladstone-UCSF Institute of Genomic Immunology: Kole Roybal, Ansuman Satpathy, and Matthew Spitzer.

Awards Gladstone Experts Genomic Immunology